Vanda Bid For Clarification On Obviousness Standard Turned Away By High Court
WASHINGTON, D.C. — The U.S. Supreme Court on April 22 denied a petition for a writ of certiorari by Vanda Pharmaceuticals Inc., which sought to undo findings that four patents relating...To view the full article, register now.
Already a subscriber? Click here to view full article